Movetis

Movetis was a pharmaceutical company headquartered in Belgium. It was founded in 2006 as a spin-off from parent company Johnson & Johnson. The company specialized in pharmaceuticals for treating gastro-intestinal disorders.

The primary drug produced by Movetis was Prucalopride (known by the brand name "Resolor") , indicated for cases of chronic constipation.

History

Movetis was founded by Staf Van Reet, and was backed by venture firms Sofinnova Partners, Sofinnova Ventures and Life Sciences Partners. In December 2009, it became a public company with an IPO on the New York Stock Exchange's Euronext.[1] Shortly thereafter, it gained regulatory approval to distribute Resolor in 30 European countries.

In 2010, the company was acquired by British drugmaker Shire Plc for 428 million euros ($559 million).[2]

References

  1. ↑ Shire forges $565M buyout deal for Movetis
  2. ↑ Shire to buy Belgian drugmaker Movetis for $560mln
This article is issued from Wikipedia - version of the 10/21/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.